Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide.
There presently is no rapid method to assess the bactericidal activity of new regimens for tuberculosis. This study examined PNU-100480, TMC207, PA-824, SQ109, and pyrazinamide, singly and in various combinations, against intracellular M. tuberculosis, using whole blood culture (WBA). The addition o...
Main Authors: | Robert S Wallis, Wesley Jakubiec, Mark Mitton-Fry, Lynn Ladutko, Sheldon Campbell, Darcy Paige, Annette Silvia, Paul F Miller |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3261206?pdf=render |
Similar Items
-
Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis.
by: Robert S Wallis, et al.
Published: (2014-01-01) -
The Potentials and Difficulties of Two New Drugs, TMC 207 and PA-824, against Drug-Susceptible and Drug-Resistant Strains of Mycobacterium tuberculosis
by: Kuzeljevic, Brigitta
Published: (2013) -
To be or not to be exclusive: the sutezolid story
by: Christy Wyskiel
Published: (2016-02-01) -
To be or not to be exclusive: the sutezolid story
by: Jane Andrews
Published: (2016-02-01) -
Improved Synthesis of the Antitubercular Agent SQ109
by: Marianna Stampolaki, et al.
Published: (2021-09-01)